The OMERACT Emerging Leaders Program: The Good, the Bad, and the Future

Affiliations

• ¹ From the Faculty of Health and Applied Sciences, University of the West of England, Bristol; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Rheumatology Unit, Royal Adelaide Hospital, Adelaide; School of Public Health and Preventive Medicine, Monash University, Melbourne; Rheumatology Department, Royal North Shore Hospital; Sydney Medical School, University of Sydney, Sydney; Department of Biomedical Engineering, The University of Melbourne, Victoria, Australia. [email protected].
• ² C.A. Flurey, MSc, PhD, CPsychol, FHEA, Faculty of Health and Applied Sciences, University of the West of England; P.S. Tugwell, MD, MSc, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; R.J. Black, MBBS, FRACP, Rheumatology Unit, Royal Adelaide Hospital; S. Halls, MSc, PhD, Faculty of Health and Applied Sciences, University of the West of England; M.J. Page, BBSc (Hons), PhD, School of Public Health and Preventive Medicine, Monash University; J.C. Robson, BSc, PhD, MRCP, Faculty of Health and Applied Sciences, University of the West of England; I. Sahbudin, BM, MSc, MRCP, Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham; H.J. Siddle, BSc (Hons), MSc, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; P. Sinnathurai, BSc (Med), MBBS, FRACP, Rheumatology Department, Royal North Shore Hospital, and Sydney Medical School, University of Sydney; K.S. Stok, PhD, Department of Biomedical Engineering, The University of Melbourne; B. Richards, MBBS (Hons), MSc, Department of Rheumatology, Royal Prince Alfred Hospital, and Sydney Medical School, University of Sydney. [email protected].
• ³ From the Faculty of Health and Applied Sciences, University of the West of England, Bristol; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Rheumatology Unit, Royal Adelaide Hospital, Adelaide; School of Public Health and Preventive Medicine, Monash University, Melbourne; Rheumatology Department, Royal North Shore Hospital; Sydney Medical School, University of Sydney, Sydney; Department of Biomedical Engineering, The University of Melbourne, Victoria, Australia.
• ⁴ C.A. Flurey, MSc, PhD, CPsychol, FHEA, Faculty of Health and Applied Sciences, University of the West of England; P.S. Tugwell, MD, MSc, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; R.J. Black, MBBS, FRACP, Rheumatology Unit, Royal Adelaide Hospital; S. Halls, MSc, PhD, Faculty of Health and Applied Sciences, University of the West of England; M.J. Page, BBSc (Hons), PhD, School of Public Health and Preventive Medicine, Monash University; J.C. Robson, BSc, PhD, MRCP, Faculty of Health and Applied Sciences, University of the West of England; I. Sahbudin, BM, MSc, MRCP, Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham; H.J. Siddle, BSc (Hons), MSc, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; P. Sinnathurai, BSc (Med), MBBS, FRACP, Rheumatology Department, Royal North Shore Hospital, and Sydney Medical School, University of Sydney; K.S. Stok, PhD, Department of Biomedical Engineering, The University of Melbourne; B. Richards, MBBS (Hons), MSc, Department of Rheumatology, Royal Prince Alfred Hospital, and Sydney Medical School, University of Sydney.